Bispecific Antibodies for Cancer Therapy: A New Class of Immunotherapy

For decades, cancer treatment has relied on conventional methods such as surgery, chemotherapy, and radiotherapy. However, immunotherapy, which activates the body’s own immune system to destroy cancer cells, has brought about a revolutionary shift in recent years. Within this domain, bispecific antibodies (BsAbs) have emerged as a novel and effective class.

What are Bispecific Antibodies?

• Bispecific antibodies are specially engineered laboratory-made antibodies that can simultaneously recognize and bind to two different antigens or cell types.
• In cancer immunotherapy, their primary goal is to create a “molecular bridge” between immune cells (like T-cells) and cancer cells, enabling immune cells to directly ....